Document is current
Any future updates will be listed below
-
Authors
Cypel, Marcelo
Neyrinck, Arne
Machuca, Tiago N.
- License Information
-
More Information
Article History
Received: 24 November 2018
Accepted: 12 February 2019
First Online: 25 February 2019
Compliance with ethical standards
:
: Dr. Cypel is founder and shareholder of Perfusix Canada and XOR labs Toronto. Both of these companies are not in commercial stages. Dr. Cypel is a consultant for Lung Bioengineering and has received research support from Xvivo perfusion and United Therapeutics.
: An approval by an ethics committee was not applicable.
Free to read: This content has been made available to all.
